Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Hashimoto

Showing results (11-20 of 271) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 10, 2007
3,3-diphenylpentane skeleton as a steroid skeleton substitute: novel inhibitors of human 5alpha-reductase 1Shinnosuke Hosoda, Yuichi Hashimoto
Chemical Record (New York, N.Y.)|November 5, 2003
Synthesis of marine guanidine alkaloids and their application as chemical/biological toolsKazuo Nagasawa, Yuichi Hashimoto
PPAR Research|June 21, 2008
Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile TemplateHiroyuki Miyachi, Yuichi Hashimoto
Future Medicinal Chemistry|April 1, 2017
Progress in the medicinal chemistry of silicon: C/Si exchange and beyondShinya Fujii, Yuichi Hashimoto
Bioorganic & Medicinal Chemistry|July 30, 2005
Nuclear receptor antagonists designed based on the helix-folding inhibition hypothesisYuichi Hashimoto, Hiroyuki Miyachi
Journal of Medicinal Chemistry|February 25, 2011
Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetryMinoru Ishikawa, Yuichi Hashimoto
The Biochemical Journal|November 26, 2011
MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's disease-related mutants of amyloid β precursor protein and presenilinsNobuyuki Tachi, Yuichi Hashimoto, Masaaki Matsuoka
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 5, 2011
[Structural development study of a novel pharmacological chaperone for folding-defective rhodopsin mutants responsible for retinitis pigmentosa]Kenji Ohgane, Kosuke Dodo, Yuichi Hashimoto
Chemical & Pharmaceutical Bulletin|November 3, 2016
Dichloromaleimide (diCMI): A Small and Fluorogenic Reactive Group for Use in Affinity LabelingKosuke Chiba, Yuichi Hashimoto, Takao Yamaguchi
Chemical & Pharmaceutical Bulletin|February 3, 2009
Structure-activity relationship of bis-galloyl derivatives related to (-)-epigallocatechin gallateKosuke Dodo, Taro Minato, Yuichi Hashimoto
Pageof 28

Showing results (11-20 of 271) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|August 10, 2007
3,3-diphenylpentane skeleton as a steroid skeleton substitute: novel inhibitors of human 5alpha-reductase 1Shinnosuke Hosoda, Yuichi Hashimoto
Chemical Record (New York, N.Y.)|November 5, 2003
Synthesis of marine guanidine alkaloids and their application as chemical/biological toolsKazuo Nagasawa, Yuichi Hashimoto
PPAR Research|June 21, 2008
Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile TemplateHiroyuki Miyachi, Yuichi Hashimoto
Future Medicinal Chemistry|April 1, 2017
Progress in the medicinal chemistry of silicon: C/Si exchange and beyondShinya Fujii, Yuichi Hashimoto
Bioorganic & Medicinal Chemistry|July 30, 2005
Nuclear receptor antagonists designed based on the helix-folding inhibition hypothesisYuichi Hashimoto, Hiroyuki Miyachi
Journal of Medicinal Chemistry|February 25, 2011
Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetryMinoru Ishikawa, Yuichi Hashimoto
The Biochemical Journal|November 26, 2011
MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's disease-related mutants of amyloid β precursor protein and presenilinsNobuyuki Tachi, Yuichi Hashimoto, Masaaki Matsuoka
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 5, 2011
[Structural development study of a novel pharmacological chaperone for folding-defective rhodopsin mutants responsible for retinitis pigmentosa]Kenji Ohgane, Kosuke Dodo, Yuichi Hashimoto
Chemical & Pharmaceutical Bulletin|November 3, 2016
Dichloromaleimide (diCMI): A Small and Fluorogenic Reactive Group for Use in Affinity LabelingKosuke Chiba, Yuichi Hashimoto, Takao Yamaguchi
Chemical & Pharmaceutical Bulletin|February 3, 2009
Structure-activity relationship of bis-galloyl derivatives related to (-)-epigallocatechin gallateKosuke Dodo, Taro Minato, Yuichi Hashimoto
Pageof 28